share_log

HC Wainwright & Co. Reiterates Buy on Elevation Oncology, Maintains $6 Price Target

Moomoo 24/7 ·  Mar 7 07:40

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:ELEV) with a Buy and maintains $6 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment